Nova Patents
EP2256201A3

Modulation of eIF4E expression

Abstract

Oligomeric compounds, compositions and methods are provided for modulating the expression of eIF4E. The antisense compounds may be single- or double-stranded and are targeted to nucleic acid encoding eIF4E. Methods of using these compounds for modulation of eIF4E expression and for diagnosis and treatment of diseases and conditions associated with expression of eIF4E are provided.

Term

Term ended

Projected expiry passed 17 September 2024, 2 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both waysCites: the store holds 1 of 2

Citations
DocumentRelationOfficeCited during
WO03048315A2CitesWorld Intellectual Property Organization (WIPO)Search report